Literature DB >> 32352280

Enterovirus D68 Antivirals: Past, Present, and Future.

Yanmei Hu1, Rami Musharrafieh1, Madeleine Zheng1, Jun Wang1.   

Abstract

Enterovirus D68 (EV-D68) is an RNA virus that causes respiratory illnesses mainly in children. In severe cases, it can lead to neurological complications such as acute flaccid myelitis (AFM). EV-D68 belongs to the enterovirus genera of the Picornaviridae family, which also includes many other significant human pathogens such as poliovirus, enterovirus A71, and rhinovirus. There are currently no vaccines or antivirals against EV-D68. In this review, we present the current understanding of the link between EV-D68 and AFM, the mechanism of viral replication, and recent progress in developing EV-D68 antivirals by targeting various viral proteins and host factors that are essential for viral replication. The future directions of EV-D68 antiviral drug discovery and the criteria for drugs to reach clinical trials are also discussed.

Entities:  

Keywords:  acute flaccid myelitis; antiviral; enterovirus D68

Year:  2020        PMID: 32352280      PMCID: PMC8055446          DOI: 10.1021/acsinfecdis.0c00120

Source DB:  PubMed          Journal:  ACS Infect Dis        ISSN: 2373-8227            Impact factor:   5.084


  97 in total

1.  The activity of enviroxime against rhinovirus infection in man.

Authors:  R J Phillpotts; R W Jones; D C Delong; S E Reed; J Wallace; D A Tyrrell
Journal:  Lancet       Date:  1981-06-20       Impact factor: 79.321

Review 2.  Enterovirus D68 and acute flaccid myelitis-evaluating the evidence for causality.

Authors:  Kevin Messacar; Edwin J Asturias; Alison M Hixon; Coretta Van Leer-Buter; Hubert G M Niesters; Kenneth L Tyler; Mark J Abzug; Samuel R Dominguez
Journal:  Lancet Infect Dis       Date:  2018-02-23       Impact factor: 25.071

3.  Rupintrivir is a promising candidate for treating severe cases of enterovirus-71 infection: evaluation of antiviral efficacy in a murine infection model.

Authors:  Xiaonan Zhang; Zhigang Song; Boyin Qin; Xiaoling Zhang; Lixiang Chen; Yunwen Hu; Zhenghong Yuan
Journal:  Antiviral Res       Date:  2013-01-05       Impact factor: 5.970

4.  Inhibition of enterovirus 71 by adenosine analog NITD008.

Authors:  Cheng-Lin Deng; Huimin Yeo; Han-Qing Ye; Si-Qing Liu; Bao-Di Shang; Peng Gong; Sylvie Alonso; Pei-Yong Shi; Bo Zhang
Journal:  J Virol       Date:  2014-08-06       Impact factor: 5.103

5.  Novel antiviral agent DTriP-22 targets RNA-dependent RNA polymerase of enterovirus 71.

Authors:  Tzu-Chun Chen; Hwan-You Chang; Pei-Fen Lin; Jyh-Haur Chern; John Tsu-An Hsu; Chu-Yi Chang; Shin-Ru Shih
Journal:  Antimicrob Agents Chemother       Date:  2009-05-04       Impact factor: 5.191

6.  Cryo-EM structure of pleconaril-resistant rhinovirus-B5 complexed to the antiviral OBR-5-340 reveals unexpected binding site.

Authors:  Jiri Wald; Marion Pasin; Martina Richter; Christin Walther; Neann Mathai; Johannes Kirchmair; Vadim A Makarov; Nikolaus Goessweiner-Mohr; Thomas C Marlovits; Irene Zanella; Antonio Real-Hohn; Nuria Verdaguer; Dieter Blaas; Michaela Schmidtke
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-28       Impact factor: 11.205

7.  Crystal structure of 2C helicase from enterovirus 71.

Authors:  Hongxin Guan; Juan Tian; Bo Qin; Justyna Aleksandra Wojdyla; Bei Wang; Zhendong Zhao; Meitian Wang; Sheng Cui
Journal:  Sci Adv       Date:  2017-04-28       Impact factor: 14.136

8.  Suramin interacts with the positively charged region surrounding the 5-fold axis of the EV-A71 capsid and inhibits multiple enterovirus A.

Authors:  Peijun Ren; Yimei Zheng; Wenqi Wang; Liping Hong; Françis Delpeyroux; Fernando Arenzana-Seisdedos; Ralf Altmeyer
Journal:  Sci Rep       Date:  2017-02-20       Impact factor: 4.379

9.  Evolutionary and Functional Diversity of the 5' Untranslated Region of Enterovirus D68: Increased Activity of the Internal Ribosome Entry Site of Viral Strains during the 2010s.

Authors:  Yuki Furuse; Natthawan Chaimongkol; Michiko Okamoto; Hitoshi Oshitani
Journal:  Viruses       Date:  2019-07-08       Impact factor: 5.048

Review 10.  Antivirals and vaccines for Enterovirus A71.

Authors:  Jing-Yi Lin; Yu-An Kung; Shin-Ru Shih
Journal:  J Biomed Sci       Date:  2019-09-03       Impact factor: 8.410

View more
  7 in total

1.  Editorial of Special Column on Antiviral Drug Discovery and Pharmacology.

Authors:  Jun Wang; Hongmin Li
Journal:  Acta Pharm Sin B       Date:  2022-04-22       Impact factor: 14.903

2.  Pharmacological Characterization of the Mechanism of Action of R523062, a Promising Antiviral for Enterovirus D68.

Authors:  Chunlong Ma; Yanmei Hu; Jiantao Zhang; Jun Wang
Journal:  ACS Infect Dis       Date:  2020-08-05       Impact factor: 5.084

3.  Discovery of Potent and Broad-Spectrum Pyrazolopyridine-Containing Antivirals against Enteroviruses D68, A71, and Coxsackievirus B3 by Targeting the Viral 2C Protein.

Authors:  Yanmei Hu; Naoya Kitamura; Rami Musharrafieh; Jun Wang
Journal:  J Med Chem       Date:  2021-06-04       Impact factor: 8.039

Review 4.  Enterovirus D68 molecular and cellular biology and pathogenesis.

Authors:  Matthew J Elrick; Andrew Pekosz; Priya Duggal
Journal:  J Biol Chem       Date:  2021-01-21       Impact factor: 5.157

5.  Global prevalence and case fatality rate of Enterovirus D68 infections, a systematic review and meta-analysis.

Authors:  Amary Fall; Sebastien Kenmoe; Jean Thierry Ebogo-Belobo; Donatien Serge Mbaga; Arnol Bowo-Ngandji; Joseph Rodrigue Foe-Essomba; Serges Tchatchouang; Marie Amougou Atsama; Jacqueline Félicité Yéngué; Raoul Kenfack-Momo; Alfloditte Flore Feudjio; Alex Durand Nka; Chris Andre Mbongue Mikangue; Jean Bosco Taya-Fokou; Jeannette Nina Magoudjou-Pekam; Efietngab Atembeh Noura; Cromwel Zemnou-Tepap; Dowbiss Meta-Djomsi; Martin Maïdadi-Foudi; Ginette Irma Kame-Ngasse; Inès Nyebe; Larissa Gertrude Djukouo; Landry Kengne Gounmadje; Dimitri Tchami Ngongang; Martin Gael Oyono; Cynthia Paola Demeni Emoh; Hervé Raoul Tazokong; Gadji Mahamat; Cyprien Kengne-Ndé; Serge Alain Sadeuh-Mba; Ndongo Dia; Giuseppina La Rosa; Lucy Ndip; Richard Njouom
Journal:  PLoS Negl Trop Dis       Date:  2022-02-08

6.  Structure Prediction and Potential Inhibitors Docking of Enterovirus 2C Proteins.

Authors:  Daoqun Li; Leiliang Zhang
Journal:  Front Microbiol       Date:  2022-04-29       Impact factor: 5.640

7.  Molnupiravir and Its Active Form, EIDD-1931, Show Potent Antiviral Activity against Enterovirus Infections In Vitro and In Vivo.

Authors:  Yuexiang Li; Miaomiao Liu; Yunzheng Yan; Zhuang Wang; Qingsong Dai; Xiaotong Yang; Xiaojia Guo; Wei Li; Xingjuan Chen; Ruiyuan Cao; Wu Zhong
Journal:  Viruses       Date:  2022-05-25       Impact factor: 5.818

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.